Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

NCT00614835 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Uterine Leiomyosarcoma
Uterine Cancer

Interventions

DRUG: Docetaxel plus Gemcitabine

Sponsor

Memorial Sloan Kettering Cancer Center